Icecure Medical FY EPS $(0.32), Inline, Sales $3.23M Beat $3.14M Estimate
Icecure Medical FY EPS $(0.32), Inline, Sales $3.23M Beat $3.14M Estimate
Icecure Medical财年每股收益为0.32美元（0.32美元），同比增长，销售额为323万美元，超过预期的314万美元
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 30.43 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $3.23 million which beat the analyst consensus estimate of $3.14 million by 2.83 percent. This is a 4.67 percent increase over sales of $3.08 million the same period last year.
Icecure Medical（纳斯达克股票代码：ICCM）公布的季度亏损为每股0.32美元，符合分析师的共识预期。与去年同期每股亏损0.46美元（0.46美元）相比，增长了30.43％。该公司公布的季度销售额为323万美元，比分析师普遍预期的314万美元高出2.83％。这比去年同期的308万美元销售额增长了4.67％。